Pro-angiogenic peptides

Details Pro-angiogenic peptides Pro-angiogenic peptides

2007-12-12

2010-11-23

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S329000, C530S330000

Reexamination Certificate

active

07838497

ABSTRACT:
This present invention generally relates to peptides, compositions, treatment methods, and devices useful for the medical diagnosis and treatment of pathogenic disorders. More specifically, the invention relates to immunostimulatory peptides which can stimulate the production of therapeutically beneficial cytokines. The peptides of the invention can regulate the release of a specific pattern of cytokines that promote angiogenesis, and modulate the immune system of a subject, without inducing deleterious side effects such as inflammation. Therefore, the peptides have therapeutic importance, particularly with respect to wound healing and restoration of circulation to damaged tissues.

REFERENCES:
patent: 5641747 (1997-06-01), Popoff et al.
patent: 5677276 (1997-10-01), Dickerson et al.
patent: 5910310 (1999-06-01), Heinen et al.
patent: 5919998 (1999-07-01), Bandurski et al.
patent: 6159937 (2000-12-01), Larsen et al.
patent: 6193981 (2001-02-01), Goldstein
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 7105481 (2006-09-01), Uutela et al.
patent: 2003/0073637 (2003-04-01), Uutela et al.
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: 2005/0063937 (2005-03-01), Li et al.
patent: 2006/0024668 (2006-02-01), Hock
patent: 2006/0148093 (2006-07-01), Gygi et al.
patent: 2006/0160730 (2006-07-01), Cuttitta et al.
patent: 2006/0287234 (2006-12-01), Breen et al.
patent: 2007/0021342 (2007-01-01), Breen et al.
patent: 2007/0149475 (2007-06-01), Murray et al.
patent: 2007/0154448 (2007-07-01), Reid et al.
patent: 2008/0102076 (2008-05-01), Eggink et al.
patent: 2009/0041793 (2009-02-01), Eggink et al.
patent: 96/40903 (1996-12-01), None
patent: 00/31130 (2000-06-01), None
patent: 02/058589 (2002-08-01), None
patent: 03/091275 (2003-11-01), None
patent: 2004/011650 (2004-05-01), None
patent: 2005/087793 (2005-09-01), None
patent: WO 2005/087793 (2005-09-01), None
patent: WO 2006/105021 (2006-03-01), None
patent: 2006/063028 (2006-06-01), None
PCT/US2007/087413 International Search Report dated Jul. 29, 2008.
Sarig, et al.; “Telomeric and Tetraplex DNA Binding Properties of qTBP42: A Homoloque of the CArG Box Binding Protein CBF-A”; Biochemical and Biophysical Research Communications 1997, vol. 237, No. 3, pp. 617-623.
Chargelegue et al., “A Peptide Mimic of a Protective Epitope of Respiratory Synctial Virus Selected from a Combinatorial Library Induced Virus-Neutralizing Antibodies and Reduces Viral Loan In Vivo”, Journal of Virology, 72(3):2040-2046 (Mar. 1998).
Chersi et al., “Specificities of rabbit antisera to multiple antigen (MAP) peptides”, Journal of Biosciences, 50 (9-10):735-738 (Sep. 1, 1995) Abstract Only.
Manki et al., “Vaccination with Multiple Antigen Peptide as Rejection Antigen Peptide in Murine Leukemia”, Cancer Research, 58:1960-1964 (May 1, 1998).
Nicolaus, “Symbiotic Approach to Drug Design”, Decision Making in Drug Research, pp. 173-186 (Jan. 1, 1983).
European Search Report for European patent application No. 07869233.2 dated May 11, 2010.
Supplementary European Search Report for European application No. 07871699.0 dated May 17, 2010 (8 sheets).
International Search Report for WO/2005/087793 dated Apr. 5, 2006 (6 sheets).
Written Opinion of the International Searching Authority for WO/2005/087793 dated Apr. 5, 2006 (7 sheets).
International Search Report for WO/2006/063028 dated Nov. 16, 2006 (6 sheets).
Written Opinion of the International Searching Authority for WO/2006/063028 dated Nov. 16, 2006 (9 sheets).
Written Opinion of the International Searching Authority for WO/2008/076815 dated Jul. 29, 2008 (6 sheets).
Written Opinion of the International Searching Authority for WO/2008/076824 dated Aug. 5, 2008 (6 sheets).
Ciesielski et al., “Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model”, Cancer Immunol Immunother, 54:107-119 (2005).
Eggink et al., “A biologically active peptide mimetic of N-acetylgalactosamine/galactose”, BMC Research Notes, 2:23 (2009).
Olszewska et al., “Protection against Measles Virus-Induced Encephalitis by Anti-mimotope Antibodies: The Role of Antibody Affinity”, Virology, 272(1):98-105 (Jun. 20, 2000).

Affiliated with

Also associated with

Rating

Pro-angiogenic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pro-angiogenic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro-angiogenic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4213983